Cumulative Regulatory Load:
An exploration of why some individuals do not return to baseline following illness, injury, or chronic physiological stress
ABSTRACT
Some individuals experience a loss of functional capacity following illness, injury, toxic exposure, trauma, or prolonged physiological or emotional stress and do not return to their prior baseline despite unremarkable medical testing.
Cumulative regulatory load refers to the total physiological demand placed on nervous system–mediated regulatory processes over time. When regulatory demand persistently exceeds available biological resources, the system may shift toward protective allocation patterns that prioritize short-term stability over long-term efficiency.
This article introduces cumulative regulatory load as a functional lens for understanding why some individuals do not return to baseline following a physiological crash, even in the absence of clearly identifiable structural pathology or conclusive testing.
INTRODUCTION
Many chronic health conditions are characterized by a change in baseline function that is difficult to localize structurally.
Individuals may report:
a sudden or gradual loss of exercise tolerance
increased recovery time following exertion
inconsistent energy availability
orthostatic intolerance
cognitive fatigue
or increased sensitivity to environmental demands
These changes may occur following infection, toxic exposure, physical injury, trauma, prolonged overexertion, or periods of sustained emotional or physiological stress.
In many cases, laboratory or imaging findings remain within normal range despite ongoing functional impairment.
A possible explanation for this pattern is that cumulative physiological demand has exceeded the system’s capacity to regulate and recover efficiently over time.
REGULATORY LOAD AND BASELINE STABILITY
Under ordinary circumstances, the nervous system coordinates the distribution of biological resources across multiple physiological systems in order to maintain stability and support recovery following stress or exertion.
This coordination requires metabolic support and ongoing regulatory effort.
When demands are:
prolonged
repetitive
multi-systemic
or occur without adequate recovery
regulatory processes may require sustained effort to maintain functional stability.
Over time, this may result in a mismatch between the demand placed on regulatory systems, and the biological resources available to meet that demand
In some cases, this mismatch may contribute to a persistent shift in how physiological resources are allocated or conserved.
This shift may present as:
reduced exertion tolerance
post-exertional symptom exacerbation
delayed recovery following activity
inconsistent energy availability
reduced tolerance to additional physiological stressors such as illness or injury
or difficulty returning to baseline following stress
Importantly, this pattern does not necessarily indicate structural damage. In many cases, it may reflect an adaptive response that has persisted beyond the context in which it was initially protective.
FUNCTIONAL IMPLICATIONS IN CHRONIC CONDITIONS
Reduced regulatory capacity may be relevant in conditions such as:
Postural Orthostatic Tachycardia Syndrome (POTS)
Dysautonomia
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
Post-treatment Lyme disease
Mast Cell Activation Syndrome (MCAS)
Post-viral syndromes
Mold-related illness
Complex trauma-associated chronic illness
In these populations, symptoms may:
fluctuate unpredictably
worsen following otherwise manageable activity
or persist despite conventional treatment approaches
Cumulative regulatory load is not proposed as a replacement for structural or disease-specific models, but as a complementary framework for understanding why some individuals may not return to baseline following a physiological stressor despite conventional treatment or unremarkable diagnostic findings.
AUTHOR’S NOTE ON SCOPE AND INTERPRETATION
This article is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment.
Cumulative regulatory load represents one of many factors that may contribute to persistent physiological instability. Structural, infectious, immunological, or environmental contributors should be evaluated by a qualified healthcare provider where appropriate.
The concepts presented here are offered as a functional framework for understanding how nervous system resource allocation may interact with broader physiological processes in certain populations.
REFERENCES
Komaroff, A. L., & Lipkin, W. I. (2021). Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of post-acute COVID-19 syndrome. Trends in Molecular Medicine, 27(9), 895–906. https://doi.org/10.1016/j.molmed.2021.06.002
Missailidis, D., Annesley, S. J., Fisher, P. R., & Sanislav, O. (2022). Mitochondrial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review. Frontiers in Immunology, 13, 888955. https://doi.org/10.3389/fimmu.2022.888955
Proal, A. D., & VanElzakker, M. B. (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology, 12, 698169. https://doi.org/10.3389/fmicb.2021.698169
Raj, S. R., Guzman, J. C., Harvey, P., Richer, L., Schondorf, R., Seifer, C., Thibodeau-Jarry, N., & Sheldon, R. S. (2021). Autonomic dysfunction in post-acute sequelae of COVID-19. Nature Reviews Cardiology, 18(11), 793–804. https://doi.org/10.1038/s41569-021-00640-6
Stussman, B., Williams, A., Snow, J., Gavin, A., Scott, R., Nath, A., & Walitt, B. (2022). Characterization of post-exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Neurology, 13, 813752. https://doi.org/10.3389/fneur.2022.813752
Nacul, L., Lacerda, E., Pheby, D., Campion, P., Molokhia, M., Fayyaz, S., Leite, J. C., Poland, F., Howe, A., Drachler, M. L., & Curran, H. (2020). Evidence of reduced cardiopulmonary reserve in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine, 18(1), 3. https://doi.org/10.1186/s12967-020-02264-5
